Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Change in Accured Expenses (2017 - 2025)

CorMedix (CRMD) has disclosed Change in Accured Expenses for 11 consecutive years, with $52.3 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 248.94% to $52.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $100.8 million through Dec 2025, up 338.42% year-over-year, with the annual reading at $100.8 million for FY2025, 338.42% up from the prior year.
  • Change in Accured Expenses hit $52.3 million in Q4 2025 for CorMedix, down from $54.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $54.7 million in Q3 2025 to a low of -$6.6 million in Q2 2025.
  • Historically, Change in Accured Expenses has averaged $7.3 million across 5 years, with a median of $807375.0 in 2022.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 4758.3% in 2021 and later soared 484.49% in 2025.
  • Year by year, Change in Accured Expenses stood at $1.1 million in 2021, then fell by 26.81% to $807375.0 in 2022, then tumbled by 209.6% to -$884872.0 in 2023, then skyrocketed by 1793.16% to $15.0 million in 2024, then skyrocketed by 248.94% to $52.3 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CRMD at $52.3 million in Q4 2025, $54.7 million in Q3 2025, and -$6.6 million in Q2 2025.